Vigilant Capital Management, LLC / ABT
Vigilant Capital Management, LLC’s Abbott Laboratories Position
Does Vigilant Capital Management, LLC own Abbott Laboratories (ABT)? Yes — 389.5K shares worth $42M (+3.17% of its 13F portfolio) as of Q2 2023, up from 377.9K shares the prior filed quarter.
Position Value
$42M
Q2 2023
Shares
389.5K
% of Portfolio
+3.17%
Quarters Held
19
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2023 | 389.5K | $42M | +3.17% |
| Q1 2023 | 377.9K | $38M | +3.11% |
| Q4 2022 | 361.5K | $40M | +3.39% |
| Q3 2022 | 346.6K | $34M | +3.15% |
| Q2 2022 | 331.8K | $36M | +3.11% |
| Q1 2022 | 324.5K | $38M | +2.93% |
| Q4 2021 | 311.3K | $44M | +3.07% |
| Q3 2021 | 297.5K | $35M | +2.82% |
| Q2 2021 | 290.2K | $34M | +2.72% |
| Q1 2021 | 271.2K | $33M | +2.89% |
| Q4 2020 | 251.8K | $28M | +2.64% |
| Q3 2020 | 245.8K | $27M | +2.93% |
| Q2 2020 | 245.3K | $22M | +2.73% |
| Q1 2020 | 246.7K | $19M | +2.84% |
| Q4 2019 | 245.6K | $21M | +2.47% |
| Q3 2019 | 243.1K | $20M | +2.65% |
| Q2 2019 | 249.6K | $21M | +2.80% |
| Q1 2019 | 254.8K | $20M | +2.84% |
| Q4 2018 | 279.2K | $20M | +3.20% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Vigilant Capital Management, LLC’s full portfolio or all institutional holders of ABT.